Planning Committee
Stephen C. Mathai, MD, MHS, FCCP
Committee Chair
Assistant Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Johns Hopkins University School of Medicine
Baltimore, Md.
Vallerie V. McLaughlin, MD, FACC, FAHA
Committee Advisor
Kim A. Eagle, MD Endowed Professor of Cardiovascular Medicine
Director, Pulmonary Hypertension Program
Department of Internal Medicine
Division of Cardiovascular Medicine
University of Michigan Medical School
Ann Arbor, Mich.
Eric D. Austin, MD, MSCI
Assistant Professor of Pediatrics
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Department of Pediatrics
Vanderbilt University School of Medicine
Nashville, Tenn.
Christopher Barnett, MD, MPH
Director, Pulmonary Hypertension Program
Medstar Washington Hospital Center
Washington D.C.
Lorinda Chung, MD, MS
Associate Professor of Medicine
Stanford University School of Medicine Division of Immunology and Rheumatology
VA Palo Alto Health Care System
Stanford, Calif.
Jean M. Elwing, MD, FCCP
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
Division of Pulmonary, Critical Care, and Sleep Medicine
University of Cincinnati
Cincinnati, Ohio
Nick H. Kim, MD
Clinical Professor of Medicine
Director, Pulmonary Vascular Medicine
Director, Fellowship Program
Division of Pulmonary and Critical Care Medicine
University of California, San Diego
La Jolla, Calif.
Richard A. Krasuski, MD
Duke University School of Medicine
Durham, N.C.
Tim Lahm, MD
Assistant Professor of Medicine
Division of Pulmonary, Allergy, Critical Care, Occupational and Sleep Medicine
Indiana University School of Medicine
Richard L. Roudebush VA Medical Center
Indianapolis, Ind.
This activity is jointly provided by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association.
DIAMOND
|
PLATINUM
|
GOLD
|
Actelion Pharmaceuticals US, Inc. | Gilead Sciences, Inc. | United Therapeutics Corporation |